RBC Europe’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-450
| Closed | -$22.7K | – | 755 |
|
|
2021
Q3 | $22.7K | Sell |
450
-50
| -10% | -$2.52K | ﹤0.01% | 754 |
|
|
2021
Q2 | $39.2K | Hold |
500
| – | – | ﹤0.01% | 647 |
|
|
2021
Q1 | $28.6K | Hold |
500
| – | – | ﹤0.01% | 678 |
|
|
2020
Q4 | $41.9K | Hold |
500
| – | – | ﹤0.01% | 562 |
|
|
2020
Q3 | $17.9K | Hold |
500
| – | – | ﹤0.01% | 665 |
|
|
2020
Q2 | $12.1K | Hold |
500
| – | – | ﹤0.01% | 729 |
|
|
2020
Q1 | $8.76K | Hold |
500
| – | – | ﹤0.01% | 740 |
|
|
2019
Q4 | $8.71K | Hold |
500
| – | – | ﹤0.01% | 824 |
|
|
2019
Q3 | $7.66K | Sell |
500
-215
| -30% | -$3.29K | ﹤0.01% | 836 |
|
|
2019
Q2 | $14.8K | Hold |
715
| – | – | ﹤0.01% | 716 |
|
|
2019
Q1 | $16.6K | Buy |
715
+615
| +615% | +$14.3K | ﹤0.01% | 699 |
|
|
2018
Q4 | $2.07K | Hold |
100
| – | – | ﹤0.01% | 1000 |
|
|
2018
Q3 | $2.17K | Hold |
100
| – | – | ﹤0.01% | 1043 |
|
|
2018
Q2 | $1.53K | Buy |
+100
| New | +$1.53K | ﹤0.01% | 1066 |
|